PharmaBlock Sciences (Nanjing), Inc. (SHE:300725)

China · Delayed Price · Currency is CNY

55.35

+3.12 (5.97%)

Sep 30, 2026, 3:04 PM CST

Market Cap	12.89B +36.5%
Revenue (ttm)	2.11B +13.5%
Net Income	210.68M +9.0%
EPS	0.94 -1.8%
Shares Out	232.97M
PE Ratio	58.78
Forward PE	53.22
Dividend	0.20 (0.36%)
Ex-Dividend Date	Aug 25, 2026

Volume	33,840,261
Open	52.91
Previous Close	52.23
Day's Range	51.11 - 57.55
52-Week Range	30.90 - 57.55
Beta	0.61
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 30, 2026

About SHE:300725

PharmaBlock Sciences (Nanjing), Inc. provides chemistry products and services throughout the pharmaceutical research and development, and commercial manufacturing in China and internationally. It offers medicinal chemistry-oriented SAR/SPR tool kits for molecule design; building blocks enabled libraries, including fragment-based drug discovery, and mega virtual library screening to support the discovery of novel hit compounds; custom synthesis (FFS); and full time equivalent (FTE). The company also provides small molecule drug substance CDMO se... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 2006

Employees 2,593

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 300725

Full Company Profile

Financial Performance

In 2025, SHE:300725's revenue was 1.97 billion, an increase of 16.93% compared to the previous year's 1.69 billion. Earnings were 183.74 million, a decrease of -16.31%.

Financial Statements